Cargando…
Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy
Myostatin is a secreted signaling molecule that normally acts to limit muscle growth. As a result, there is extensive effort directed at developing drugs capable of targeting myostatin to treat patients with muscle loss. One potential concern with this therapeutic approach in patients with muscle de...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581601/ https://www.ncbi.nlm.nih.gov/pubmed/26206886 http://dx.doi.org/10.1093/hmg/ddv288 |